JP2006506367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006506367A5 JP2006506367A5 JP2004544577A JP2004544577A JP2006506367A5 JP 2006506367 A5 JP2006506367 A5 JP 2006506367A5 JP 2004544577 A JP2004544577 A JP 2004544577A JP 2004544577 A JP2004544577 A JP 2004544577A JP 2006506367 A5 JP2006506367 A5 JP 2006506367A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- peptide
- ppi
- bioadhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL15228902A IL152289A0 (en) | 2002-10-14 | 2002-10-14 | Method and composition for inhibiting h.pylori infection in a mammalian tissue |
| PCT/IB2003/004453 WO2004034957A2 (en) | 2002-10-14 | 2003-10-09 | Methods for treatment of helicobacter pylori-associated disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006506367A JP2006506367A (ja) | 2006-02-23 |
| JP2006506367A5 true JP2006506367A5 (https=) | 2006-11-24 |
Family
ID=29765063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004544577A Pending JP2006506367A (ja) | 2002-10-14 | 2003-10-09 | ヘリコバクター・ピロリ関連疾患の治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7271146B2 (https=) |
| EP (1) | EP1567181A4 (https=) |
| JP (1) | JP2006506367A (https=) |
| AU (1) | AU2003274392A1 (https=) |
| CA (1) | CA2503325A1 (https=) |
| IL (1) | IL152289A0 (https=) |
| WO (1) | WO2004034957A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005020879A2 (en) * | 2003-08-27 | 2005-03-10 | Vecta Ltd. | Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
| JP2007506730A (ja) * | 2003-09-24 | 2007-03-22 | ベクタ・リミテッド | ペンタガストリンを含む胃酸分泌刺激用経口組成物 |
| US7981908B2 (en) * | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
| US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| PL2046334T3 (pl) * | 2006-07-25 | 2015-02-27 | Vecta Ltd | Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI |
| EP2197469A2 (en) * | 2007-09-11 | 2010-06-23 | Mondobiotech Laboratories AG | Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection |
| US20110046079A1 (en) * | 2008-01-16 | 2011-02-24 | Mullin James M | Use of Proton Pump Inhibitors as Drug Delivery Adjuvants |
| EP2601947A1 (en) * | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
| US9700514B1 (en) | 2014-08-20 | 2017-07-11 | Darren Rubin | Single solid oral dosage forms for treating Helicobacter pylori infection and duodenal ulcer disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4891356A (en) | 1987-07-15 | 1990-01-02 | Brigham & Women's Hospital | Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| CA2331834A1 (en) * | 1998-06-18 | 1999-12-23 | Michal Y. Chowers | Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders |
| US7365047B1 (en) * | 1999-09-28 | 2008-04-29 | The Regents Of The University Of California | Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
| FR2832311B1 (fr) * | 2001-11-21 | 2004-04-16 | Besins Int Belgique | Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations |
-
2002
- 2002-10-14 IL IL15228902A patent/IL152289A0/xx unknown
-
2003
- 2003-10-09 WO PCT/IB2003/004453 patent/WO2004034957A2/en not_active Ceased
- 2003-10-09 CA CA002503325A patent/CA2503325A1/en not_active Abandoned
- 2003-10-09 JP JP2004544577A patent/JP2006506367A/ja active Pending
- 2003-10-09 AU AU2003274392A patent/AU2003274392A1/en not_active Abandoned
- 2003-10-09 EP EP03758376A patent/EP1567181A4/en not_active Withdrawn
- 2003-10-14 US US10/682,937 patent/US7271146B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2112920B1 (en) | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient | |
| RU2166935C2 (ru) | Таблетированная многоединичная лекарственная форма, способ ее получения, способ ингибирования секреции желудочной кислоты или лечения желудочно-кишечных заболеваний у млекопитающих и человека | |
| JP5162689B2 (ja) | 活性成分としてのパントプラゾールを含有する投与形 | |
| JP2008534438A5 (https=) | ||
| JP2004508396A (ja) | 非ステロイド性抗炎症薬およびプロトンポンプ阻害薬を含有する医薬製剤 | |
| EP1607088B1 (en) | Controlled release composition | |
| HU226580B1 (en) | Pharmaceutical formulation comprising a 2-[[(2-pyridinyl)methyl]sulfinyl] benzimidazole having anti-ulcer activity and a process for the preparation of such formulation | |
| JP2006506367A5 (https=) | ||
| ES2376466T3 (es) | Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación. | |
| CA2605839A1 (en) | Stabilized composition of a proton pump inhibitor | |
| KR20120104991A (ko) | 약학적 고체 제형 | |
| WO2007074910A1 (ja) | 放出制御固形製剤 | |
| JP5474541B2 (ja) | 小さいジカルボン酸の誘導体と組み合わせてｐｐｉを用いる胃酸分泌を阻害する組成物および方法 | |
| JP4800926B2 (ja) | 活性成分としての（ｓ）−パントプラゾールを含有する医薬組成物 | |
| JP2011520868A (ja) | 胃酸分泌を阻害するための組成物および方法 | |
| JPH0733659A (ja) | 抗潰瘍剤含有製剤 | |
| CA2740974A1 (en) | Dosage forms for the rapid and sustained elevation of gastric ph | |
| ES2466441T3 (es) | Composiciones farmacéuticas que comprenden fármaco antiinflamatorio no esteroideo, acetaminofén e inhibidor de la bomba de protones | |
| JP2006513239A5 (https=) | ||
| US20110293713A1 (en) | Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs | |
| CN100488507C (zh) | 含有泮托拉唑作为活性成分的剂型 | |
| RU2414889C2 (ru) | Фармацевтическая композиция для лечения язвы желудка и двенадцатиперстной кишки в форме твердых желатиновых капсул, содержащая рабепразол или его производные, и способ ее получения | |
| CN100457104C (zh) | 质子泵抑制剂的碱性盐 | |
| TR201605487A1 (tr) | Anti̇ülserati̇f farmasöti̇k terki̇pler | |
| HK1090546B (en) | Dosage form containing pantoprazole as active ingredient |